Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01909362 · ClinicalTrials.gov registry record
Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC)
A clinical trial of Colorectal Neoplasms and Advanced Metastatic Colorectal Cancer, sponsored by US Oncology Research.
- Completed
- Registry status
- 52
- Enrollment target
- 1
- Study location
NCT01909362 is a study of Colorectal Neoplasms and Advanced Metastatic Colorectal Cancer that has completed, run by US Oncology Research. The registered enrollment target is 52 participants, below the 576-participant average among 54 other Colorectal Neoplasms trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01909362, a study of Colorectal Neoplasms and Advanced Metastatic Colorectal Cancer, has completed, sponsored by US Oncology Research.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients are being asked to participate in this study who have colorectal cancer that has come back after initial treatment. The investigators want to improve treatment in patients with this disease. In other types of cancers, it has been possible to improve treatment by studying the gene mutations (called biomarkers) in a patient's cancer and "matching" these to existing cancer therapies or study drugs which target that specific mutation. Colorectal cancers have not been routinely tested in this way. In this study, investigators will determine whether mutational testing can be successfully done on colorectal cancers and how often mutations are detected for which there are existing drugs (or drugs in development). The results will be used to determine if treating physicians use this information in planning subsequent treatment.
Conditions Studied
Study Locations (1)
Texas
- 13 sites within US - Incl Greenville, SC and Tyler, TX
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01909362
The ClinicalTrials.gov registry entry for NCT01909362 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 576-participant average among 54 other Colorectal Neoplasms trials with a reported enrollment target (91% lower). The listed sponsor is US Oncology Research, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colorectal Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT01909362 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01909362 about?
NCT01909362 is a clinical study titled "Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC)". Patients are being asked to participate in this study who have colorectal cancer that has come back after initial treatment. The investigators want to improve treatment in patients with this disease. In other types of cancers, it has been possible to improve treatment by studying the gene mutations ...
What is the current status of trial NCT01909362?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2013-07. Estimated completion is 2014-02.
What conditions does trial NCT01909362 study?
This clinical trial studies the following conditions: Colorectal Neoplasms, Advanced Metastatic Colorectal Cancer.
Who is sponsoring clinical trial NCT01909362?
This trial is sponsored by US Oncology Research, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01909362 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
RECRUITING · Phase 3
-
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
RECRUITING
-
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
RECRUITING · Phase 1
-
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RECRUITING · Phase 1
-
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
RECRUITING · Phase 1
-
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.